Close
FINDING CURES TOGETHER<sup>SM</sup>

AACR Annual Meeting 2019

Program 

The AACR Annual Meeting Online Program Planner is now available. Users can browse and search all Annual Meeting sessions and presentations by author, title, session type, or track/organ site. While search and browse features are available to all users, Annual Meeting registrants will be able to log in and create a personal itinerary beginning Thursday, Feb. 14.

A list of all scheduled sessions as of March 1, 2019 is available in the print Program Guide (PDF). However, please note that sessions and speakers may change at any time. The most current session and presentation information is always available through the AACR Annual Meeting Online Program Planner and Meeting App.

New this year, educational programming will begin on Friday, March 29, at 3 p.m. and continue through Saturday, March 30. More than 60 unique Educational Sessions and Methods Workshops are included in this program, and sessions are open to all meeting registrants.

The Opening Ceremony and the Opening Plenary Session will take place on Sunday morning, March 31. The meeting will conclude at 1:30 p.m. on Wednesday, April 3. View the Schedule At-A-Glance.


Educational
Program - Friday, March 29
3-5 p.m., 5:15-7:15 p.m.

Education Sessions

  • Biomarker Studies: Study Design and Statistical Considerations
  • Genetic Predispositions to Childhood Leukemias: Implications for Pathogenesis and Screening
  • Host versus Tumor Autophagy in Cancer
  • Immune-Targeted Biomarker Incorporation into Therapeutic Decision Making
  • Intersection of Radiation and Immune Therapy
  • Modulation of the Gut Microbiome to Treat Dysbiosis and Cancer
  • Molecular Pathology for Cancer Researchers: Present and Future
  • Preleukemia and Clonal Hematopoiesis
  • Quantitative Approaches to Study Cancer Evolution and Heterogeneity

Methods Workshops

  • Controversies in Replication cfDNA Measurements
  • Defining Tumor Organ-systems with Single Cell Transcriptomics
  • Game-Changing Technologies for High Through-Put Functional Characterization of Cancer Gene Variants


Educational Program
- Saturday, March 30
8-10 a.m., 10:15 a.m.-12:15 p.m., 1-3 p.m., 3:15-5:15 p.m., 5:15-7:15 p.m.

Education Sessions

  • Cancer Genomic Reference Samples: MDIC Somatic Reference Sample Collaborative Initiative
  • CAR-T Therapy State of the Art
  • Characterizing Cancer Disparities Nationally and Internationally Using Publicly Available Data: Recent Advances
  • Chemistry to the Clinic: Part 1: Lead Optimization in Cancer Drug Discovery
  • Chemistry to the Clinic: Part 2: Novel Chemical Tools and Leads for Unprecedented Targets
  • Chemistry to Clinic: Part 3: Unconventional Modalities to Extend the Antitumor Target Space
  • Co-evolution of Tumor and Microenvironment in Cancer Metastasis
  • CtDNA for Cancer Stratification, Monitoring, Clonal Tracking, MRD Detection, and Early Diagnosis
  • Diverse Functions of Neutrophils in Cancer
  • East Looks West: Chinese Pharma Explodes Western Markets
  • The Endothelium and Fluid Flows: Linking Metastasis and Immunity
  • The Evolution of the Art and Science of Go/No Go Decisions in Cancer Drug Development
  • Extracellular Vesicles and Intercellular Communication in Cancer
  • Fibroblasts in the Driver’s Seat: Impact on Tumor Progression and Therapy Resistance
  • Fluorescence Image-Guided Surgery for Improved Clinical Outcomes
  • From Cancer Genomics to the 3D Organization of the Genome
  • Functional Follow-Up of Microbiome Associations for Cancer Epidemiology Studies
  • Impact of a Brexit on Oncology Drug Development and Regulation
  • Integrating Tumor Immunology and Molecular Epidemiology
  • Making Your Voice Heard: How to Effectively Advocate for Cancer Research and Science-based Policy
  • Metabolic Drivers of Cancer
  • Molecular Regulation of Cancer Inflammation, Progression, and Treatment Resistance
  • Obesity: The Effects of Local and Systemic Inflammation on Cancer
  • Oncolytic Virus Therapy
  • Ordering Genomic Changes as Actionable Targets in Pediatric Cancers
  • Organoids as Model Systems in Cancer
  • Pancreatic Tumor Microenvironment
  • Personalized Circulating Tumor DNA Analysis for Minimal Residual Disease Detection
  • Precision Medicine in 2019
  • Resistance to Therapies and Cancer Cell Dormancy
  • Single-Cell and Spatial Genomics
  • Stromal Niches for Organ-Tropic Metastasis
  • Systems Biology Approaches to Cancer
  • Tools for Machine Learning in Cancer Image Analysis
  • Tumor Immunology and Immunotherapy for Nonimmunologists: Roundtable Discussions
  • Tumor Immunology and Immunotherapy for Nonimmunologists: Standard Cancer Therapies are Ultimately Immunotherapies
  • Update on Young Women’s Breast Cancer
  • Vascular-Immune Cell Cross-Talk: Implications for Cancer Immunotherapy 
  • West Looks East: Western Pharma Explores the China Mainland

Methods Workshops

  • BRCA1 Variants of Unknown Significance (VUS): New Vistas in the Assessment of Cancer Risk
  • Clinical Trial Design: Part 1: The ABCs of Doing Cancer Clinical Trials
  • Clinical Trial Design: Part 2: Novel Trial Designs
  • Clinical Trial Design: Part 3: Biomarker-Directed Clinical Trials 
  • Clinical Trial Design: Part 4
  • Deciphering and Targeting Lysosomes in Cancer
  • Designing Biomarker Studies to Achieve Desired Clinical Applications 
  • Methods for Utilizing the Microbiome in Cancer Epidemiology Research
  • Methods to Study Metabolism for Cancer Research 
  • Modeling Tumor Dormancy
  • Novel Imaging Strategies in the Metastatic Niche 
  • Sample Size and Power Workshop for Basic, Translational, and Clinical Studies 

Top of page